Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations.
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Shinkyo
S
Yoon
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Dae Ho
DH
Lee
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Sang-We
SW
Kim